Apoptosis-inducing factor is involved in the regulation of caspase-independent neuronal cell death

J Cell Biol. 2002 Aug 5;158(3):507-17. doi: 10.1083/jcb.200202130. Epub 2002 Jul 29.

Abstract

Caspase-independent death mechanisms have been shown to execute apoptosis in many types of neuronal injury. P53 has been identified as a key regulator of neuronal cell death after acute injury such as DNA damage, ischemia, and excitotoxicity. Here, we demonstrate that p53 can induce neuronal cell death via a caspase-mediated process activated by apoptotic activating factor-1 (Apaf1) and via a delayed onset caspase-independent mechanism. In contrast to wild-type cells, Apaf1-deficient neurons exhibit delayed DNA fragmentation and only peripheral chromatin condensation. More importantly, we demonstrate that apoptosis-inducing factor (AIF) is an important factor involved in the regulation of this caspase-independent neuronal cell death. Immunofluorescence studies demonstrate that AIF is released from the mitochondria by a mechanism distinct from that of cytochrome-c in neurons undergoing p53-mediated cell death. The Bcl-2 family regulates this release of AIF and subsequent caspase-independent cell death. In addition, we show that enforced expression of AIF can induce neuronal cell death in a Bax- and caspase-independent manner. Microinjection of neutralizing antibodies against AIF significantly decreased injury-induced neuronal cell death in Apaf1-deficient neurons, indicating its importance in caspase-independent apoptosis. Taken together, our results suggest that AIF may be an important therapeutic target for the treatment of neuronal injury.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antibodies / pharmacology
  • Apoptosis / physiology*
  • Apoptosis Inducing Factor
  • Apoptotic Protease-Activating Factor 1
  • Brain / cytology
  • Brain / embryology*
  • Brain / enzymology
  • Camptothecin / pharmacology
  • Caspase Inhibitors
  • Caspases / metabolism*
  • Cell Survival / drug effects
  • Cell Survival / physiology
  • Cells, Cultured
  • DNA Damage / drug effects
  • DNA Damage / physiology
  • Enzyme Inhibitors / pharmacology
  • Flavoproteins / genetics
  • Flavoproteins / metabolism*
  • Gene Frequency / physiology
  • In Situ Nick-End Labeling
  • Membrane Proteins / genetics
  • Membrane Proteins / metabolism*
  • Mice
  • Mice, Knockout
  • Mitochondria / genetics
  • Mitochondria / metabolism
  • Neurodegenerative Diseases / drug therapy
  • Neurodegenerative Diseases / enzymology*
  • Neurodegenerative Diseases / physiopathology
  • Neurons / cytology
  • Neurons / enzymology*
  • Proteins / genetics
  • Proteins / metabolism*
  • Proto-Oncogene Proteins / genetics
  • Proto-Oncogene Proteins / metabolism
  • Proto-Oncogene Proteins c-bcl-2 / genetics
  • Proto-Oncogene Proteins c-bcl-2 / metabolism
  • Transfection
  • Tumor Suppressor Protein p53 / drug effects
  • Tumor Suppressor Protein p53 / genetics
  • Tumor Suppressor Protein p53 / metabolism
  • bcl-2-Associated X Protein

Substances

  • Antibodies
  • Apaf1 protein, mouse
  • Apoptosis Inducing Factor
  • Apoptotic Protease-Activating Factor 1
  • Bax protein, mouse
  • Caspase Inhibitors
  • Enzyme Inhibitors
  • Flavoproteins
  • Membrane Proteins
  • AIFM1 protein, mouse
  • Proteins
  • Proto-Oncogene Proteins
  • Proto-Oncogene Proteins c-bcl-2
  • Tumor Suppressor Protein p53
  • bcl-2-Associated X Protein
  • Caspases
  • Camptothecin